397 related articles for article (PubMed ID: 17249857)
1. Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.
Insinga RP; Itzler RF; Pellissier JM
Pharmacoeconomics; 2007; 25(2):155-69. PubMed ID: 17249857
[TBL] [Abstract][Full Text] [Related]
2. Healthcare resource utilization and costs associated with herpes zoster in the US.
Johnson BH; Palmer L; Gatwood J; Lenhart G; Kawai K; Acosta CJ
J Med Econ; 2016 Oct; 19(10):928-35. PubMed ID: 27149530
[TBL] [Abstract][Full Text] [Related]
3. Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans.
White RR; Lenhart G; Singhal PK; Insinga RP; Itzler RF; Pellissier JM; Segraves AW
Pharmacoeconomics; 2009; 27(9):781-92. PubMed ID: 19757871
[TBL] [Abstract][Full Text] [Related]
4. Burden of herpes zoster and post-herpetic neuralgia in Sweden.
Nilsson J; Cassel T; Lindquist L
BMC Infect Dis; 2015 May; 15():215. PubMed ID: 26002038
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and long-term disease burden of herpes zoster and postherpetic neuralgia in Taiwan: a population-based, propensity score-matched cohort study.
Lu WH; Lin CW; Wang CY; Chen LK; Hsiao FY
BMC Public Health; 2018 Mar; 18(1):369. PubMed ID: 29554872
[TBL] [Abstract][Full Text] [Related]
6. Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older.
Stein AN; Britt H; Harrison C; Conway EL; Cunningham A; Macintyre CR
Vaccine; 2009 Jan; 27(4):520-9. PubMed ID: 19027048
[TBL] [Abstract][Full Text] [Related]
7. Healthcare Resource Utilisation Associated with Herpes Zoster in a Prospective Cohort of Older Australian Adults.
Karki S; Newall AT; MacIntyre CR; Heywood AE; McIntyre P; Banks E; Liu B
PLoS One; 2016; 11(8):e0160446. PubMed ID: 27483007
[TBL] [Abstract][Full Text] [Related]
8. Health care expenditure burden of persisting herpes zoster pain.
Dworkin RH; White R; O'Connor AB; Hawkins K
Pain Med; 2008 Apr; 9(3):348-53. PubMed ID: 18366512
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
10. Costs of herpes zoster complications in older adults: A cohort study of US claims database.
Meyers JL; Candrilli SD; Rausch DA; Yan S; Patterson BJ; Levin MJ
Vaccine; 2019 Feb; 37(9):1235-1244. PubMed ID: 30685248
[TBL] [Abstract][Full Text] [Related]
11. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis.
Curran D; Hunjan M; El Ghachi A; El-Hahi Y; Bianco V; Ferreira G
BMJ Open; 2019 Aug; 9(8):e023502. PubMed ID: 31462457
[TBL] [Abstract][Full Text] [Related]
13. Healthcare costs of acute and chronic pain associated with a diagnosis of herpes zoster.
Dworkin RH; White R; O'Connor AB; Baser O; Hawkins K
J Am Geriatr Soc; 2007 Aug; 55(8):1168-75. PubMed ID: 17661954
[TBL] [Abstract][Full Text] [Related]
14. Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States.
Meyers JL; Madhwani S; Rausch D; Candrilli SD; Krishnarajah G; Yan S
Hum Vaccin Immunother; 2017 Aug; 13(8):1861-1872. PubMed ID: 28605285
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of lung cancer and the associated costs of treatment failure in the United States.
Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH
Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249
[TBL] [Abstract][Full Text] [Related]
16. Economic Burden of Herpes Zoster and Post-Herpetic Neuralgia in Adults 60 Years of Age or Older: Results from a Prospective, Physician Practice-Based Cohort Study in Kushiro, Japan.
Nakamura H; Mizukami A; Adachi K; Matthews S; Holl K; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Sato K; Matsuki T; Kaise T; Curran D
Drugs Real World Outcomes; 2017 Dec; 4(4):187-198. PubMed ID: 28988331
[TBL] [Abstract][Full Text] [Related]
17. Economic burden of herpes zoster among skilled nursing facility residents in the United States.
Ma L; White RR; Narayanan S; Schmader KE
J Am Med Dir Assoc; 2012 Jan; 13(1):54-9. PubMed ID: 21450176
[TBL] [Abstract][Full Text] [Related]
18. Healthcare costs associated with varicella and herpes zoster in Norway.
Haugnes H; Flem E; Wisløff T
Vaccine; 2019 Jun; 37(29):3779-3784. PubMed ID: 31151798
[TBL] [Abstract][Full Text] [Related]
19. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
[TBL] [Abstract][Full Text] [Related]
20. Cost of herpes zoster and herpes zoster-related complications among immunocompromised individuals.
Meyers JL; Candrilli SD; Rausch DA; Yan S; Patterson BJ; Levin MJ
Vaccine; 2018 Oct; 36(45):6810-6818. PubMed ID: 30249425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
